PRKD3 and breast cancer: Although previous studies have demonstrated that PRKD3 is an oncogenic function in invasive breast cancer [50], and MET has a potential prognostic value in breast cancer [51], our study further elicits their potential prognostic values in predicting the outcome of endocrine therapy.